By addressing these knowledge gaps, semaglutide may emerge as an important therapeutic option for managing both metabolic dysfunction and cognitive decline in patients with T2DM
Nausea and vomiting rank amongst the most frequently reported side effects, affecting up to one in five users
In order to keep weight off, people need to continue taking the GLP-1 medications indefinitely
This delay is therapeutically useful it extends satiety and reduces caloric intake but it also causes the cramping, bloating, and abdominal pressure that researchers describe variously as "stomach pains on reta," "cramping on retatrutide," or simply that their "stomach hurts on reta." For the complete adverse event profile across all body systems, see our retatrutide side effects clinical data breakdown
Testimonials reflect individual experiences and are not a guarantee of results
Literature references: Pizzorno J